by Barry101 | Dec 29, 2017 | Press Release
ORLANDO, Fla., Dec. 29, 2017 — Hemispherx Biopharma, Inc. (NYSE MKT:HEB), focused on pharmaceutical research, today announced, that it will be presenting at the Biotech Showcase™ 2018. The conference will be held January 8-10, 2018 at the Hilton San...
by Barry101 | Dec 20, 2017 | Press Release
NEW BRUNSWICK, N.J., Dec. 20, 2017 — Hemispherx Biopharma (NYSE American:HEB) said, its Contract Manufacturing Organization (CMO) for Ampligen® has completed a commercial scale demonstration/engineering manufacturing run, along with the...
by Barry101 | Dec 19, 2017 | Press Release
Letter to Shareholders Posted on WebsiteRevenue Up, Burn Rate Down Dramatically; Progress Cited with FDA Discussions on Ampligen; Manufacturing Facility for FDA-Approved Alferon N Fully Repaired; Immuno-oncology Seen as Major OpportunityPHILADELPHIA, Dec. 19, 2017...
